Evaluation of cost of disease: Assessing the burden to society of asthma in children in the European Union

M. Marle,J. Bruil,S. Detmar
DOI: https://doi.org/10.1111/j.1398-9995.2005.00692.x
2005-02-01
Abstract:Asthma and allergies have become increasingly prevalent over the last few decades throughout the WHO European Region, with an average of more than 10% of children suffering from asthmatic symptoms. Asthma is one of the most common chronic diseases and it is a complex and heterogeneous disorder where genetics and environment play an interacting role. Childhood asthma is a major global health problem, which exerts a substantial burden on family, health care, and society as a whole. In decision-making on interventions to reduce the burden of childhood asthma an overview of the cost-of-illness of childhood asthma is an essential first step. In this report the cost-of-illness of childhood asthma in the countries of the European Union is assessed by order of the European Commission. Also the countries that will enter the European Union at the 1st of May 2004 are included. The 25 countries of the European Union (EU25) from May 1st 2004 onwards are Austria*, Belgium*, Cyprus, Czech Republic, Denmark*, Estonia, Finland*, France*, Germany*, Greece*, Hungary, Ireland*, Italy*, Latvia, Lithuania, Luxembourg*, Malta, Poland, Portugal*, Slovenia, Slovakia, Spain*, Sweden*, The Netherlands* and the United Kingdom*.
What problem does this paper attempt to address?